Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jianying Mu"'
Autor:
Zengru Wu, Kuanysh Kabytaev, Jianying Mu, Shawn Connolly, Nigel J. Clarke, Randie Little, Michael J. McPhaul
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 26, Iss , Pp 7-8 (2022)
Externí odkaz:
https://doaj.org/article/76b4666e872a43f3abcd53f7aea681ef
Autor:
ZENGRU WU, KUANYSH KABYTAEV, JIANYING MU, SHAWN CONNOLLY, MICHAEL J. MCPHAUL, RANDIE R. LITTLE
Publikováno v:
Diabetes. 71
The standardization of C-peptide assays is highly desirable objective. Our groups have employed the use of a Certified Reference Material (CRM) to calibrate their respective measurement procedures and comparison studies have demonstrated good agreeme
Autor:
Jianying Mu, Bo Ding, Akintunde O. Akinkuolie, Paul M. Ridker, Robert J. Glynn, Samia Mora, Michael P. Caulfield, Fredrik Nyberg, Eva Hurt-Camejo, Daniel I. Chasman, Patrick R. Lawler, Audrey Y. Chu
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 39:1182-1190
Objective— Inflammation is a causal risk factor for cardiovascular disease (CVD). sPLA 2 -IIA (group IIA secretory phospholipase A 2 ) plays an integral role in regulating vascular inflammation. Although studies investigated sPLA 2 -IIA in secondar
Autor:
Akintunde O, Akinkuolie, Patrick R, Lawler, Audrey Y, Chu, Michael, Caulfield, Jianying, Mu, Bo, Ding, Fredrik, Nyberg, Robert J, Glynn, Paul M, Ridker, Eva, Hurt-Camejo, Daniel I, Chasman, Samia, Mora
Publikováno v:
Arterioscler Thromb Vasc Biol
OBJECTIVES: Inflammation is a causal risk factor for cardiovascular disease (CVD). Group IIA secretory phospholipase A(2) (sPLA(2)-IIA) plays an integral role in regulating vascular inflammation. While studies investigated sPLA(2)-IIA in secondary pr
Autor:
Akintunde O Akinkuolie, Audrey Y Chu, Michael Caulfield, Jianying Mu, Hurt-Camejo Eva, Bo Ding, Fredrik Nyberg, Robert J Glynn, Paul M Ridker, Daniel I Chasman, Samia Mora
Publikováno v:
Circulation. 132
Background: Although group IIA secretory phospholipase A2 (sPLA2-IIA) is well appraised for its involvement in atherosclerosis by modifying LDL, its role in managing CVD risk in a primary prevention setting with low LDL-C is unknown. Furthermore, the
Publikováno v:
Pfl�gers Archiv European Journal of Physiology. 438:159-164
The effects on renal sodium excretion of giving lithium chloride (LiCl; 0.75 mmol per kg body mass) by gavage or intravenously were investigated. The experiments were carried out on Wistar-Kyoto (WKY) or spontaneously hypertensive (SHR) rats in metab